Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

The President Trump administration is investigating five college universities for potentially “wide-spread antisemitic ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

A report from Parents Defending Education alleges that since 2021, the Department of Education has awarded over $200 million ...

Despite A. O. Smith Corporation's solid financial performance, shares are still too expensive. Click here to read an analysis of AOS stock now.

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Provided figures on Russia’s and Ukraine’s current war losses; ・Stated readiness for peace talks in a four-party format ...

The nonprofit newsroom — whose founders and senior leadership are all women — has taken a innovative, youth-focused approach ...

Q4 2024 Earnings Conference Call February 4, 2025 8:00 AM ETCompany ParticipantsMatthew Rohrmann - Senior Vice President ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...